Modeling and simulation at the FDA and in industry: collaboration among statisticians, modelers and pharmacometricians
*Vikram Sinha, FDA Keywords: The talk will address the role of model-based approaches and model-informed regulatory assessments in drug development from a pharmacometric regulatory perspective with highlights on the collaboration between industry and the FDA.
|
Key Dates
-
June 3, 2014 - September 7, 2015
Online Registration -
June 3, 2015 - August 15, 2015
Housing -
July 31 - August 17, 2015
Invited Abstract Editing -
August 10, 2015
Short Course materials due from Instructors -
August 26, 2015
Advanced Registration Deadline -
September 7, 2015
Cancellation Deadline -
September 16 - 18, 2015
Marriott Wardman Park, Washington, DC